The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

The human cost Additional studies highlighted ... they are a trusted source for US patients seeking cost-effective insulin solutions.

Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). If you accidentally take too much or your blood sugar is low for ...

as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first ...

Scientists at ETH Zurich have developed a gene switch that can be activated using a simple nitroglycerin patch applied to the ...

Department of Life Sciences, University of Bath, Claverton Down, BA2 7AY Bath, U.K.